Ironwood Pharmaceuticals, Inc.
IRWD
$3.25
-$0.12-3.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.68% | 69.84% | 163.12% | -1,757.18% | -38.12% |
| Total Depreciation and Amortization | -3.16% | 1.71% | -2.51% | -1.24% | -4.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.92% | 64.90% | 188.06% | -85.40% | 177.40% |
| Change in Net Operating Assets | 391.44% | 57.04% | -217.19% | 247.22% | -208.49% |
| Cash from Operations | 56.73% | 415.79% | -175.51% | 31.16% | 53.91% |
| Capital Expenditure | 150.00% | 0.00% | 93.55% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 150.00% | 0.00% | 93.55% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 40.00% |
| Issuance of Common Stock | -- | -100.00% | 1,366.67% | -97.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 95.83% |
| Cash from Financing | -- | -100.00% | 1,366.67% | 100.04% | 45.18% |
| Foreign Exchange rate Adjustments | 1,450.00% | 95.98% | -9,142.86% | -133.33% | 180.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.82% | 404.27% | -178.45% | 5,624.71% | 102.01% |